We use a small number of cookies to give you the best experience of our website. If you continue to view the Positive Action site we'll assume that you are happy to receive these cookies. Find out exactly what cookies we use and how to turn them off.

Continue

HIV in the News

This page contains the most recent HIV related news from NAM aidsmap. You can read the full story by clicking on the headlines.

?Risky when young? or ?risky with age?: Dutch study identifies life patterns associated with higher HIV risk in gay men

A Dutch study which looked at the way gay men?s risk of HIV changed with time has used statistical analysis to isolate two kinds of ?risk trajectory? that are associated with a much higher-than-average lifetime risk of HIV. Averaged over their ?risk career?, these gay men, who between them formed ... full story

Fri, 25 May 2018

Gay men having chemsex are five times more likely to have a new HIV diagnosis than other gay men

Gay and bisexual men who reported engaging in chemsex (the use of specific drugs to enhance or facilitate sex) were five times more likely to be newly diagnosed with HIV, nine times more likely to be diagnosed with hepatitis C and four times more likely to be diagnosed with a ... full story

Wed, 23 May 2018

PrEP may make it hard to tell if someone has an HIV infection

It may be very difficult to tell if someone who has just started HIV pre-exposure prophylaxis (PrEP) has actually caught HIV just before or just after they started PrEP. This is what seems to have happened in a case where a 31-year-old man from New York, who had just started PrEP, ... full story

Wed, 23 May 2018

Dolutegravir may cause birth defects, European Medicines Agency warns

Regulatory agencies in the United States and European Union have warned that women with HIV who can become pregnant should not use the integrase inhibitor dolutegravir (Tivicay, also in Triumeq and Juluca) without effective contraception, following a report from Botswana of a higher frequency of birth defects in babies born ... full story

Mon, 21 May 2018

PrEP approved for adolescents in US

The US Food and Drug Administration (FDA) last week approved Truvada pre-exposure prophylaxis (PrEP) for adolescents, which will likely make the HIV prevention pill more widely available to a group with a disproportionately high risk of infection. Doctors in the US can prescribe approved drugs as they deem appropriate, and many ... full story

Mon, 21 May 2018

High prevalence of menopausal symptoms in women living with HIV, but very few receive treatments for them

Nine in ten women living with HIV aged 45 to 60 have hot flushes and other somatic symptoms of the menopause, but often have difficulties getting advice and care to manage them, according to an English study released today. Only 8% of women with these symptoms were currently using menopausal hormone therapy (MHT). Thanks to ... full story

Thu, 17 May 2018

Do fatigue and quality of life improve after hepatitis C is cured?

Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people with cirrhosis, but people with cirrhosis are less likely than others to experience rapid resolution of severe fatigue after successful hepatitis C treatment, according to two studies from the ... full story

Wed, 16 May 2018

Taking large numbers of non-ART drugs associated with increased risk of hospitalisation and death for HIV-positive people

Taking large numbers of medications in addition to antiretroviral therapy (ART) is associated with an increased risk of hospitalisation and death for HIV-positive individuals, investigators from the US Department of Veterans Affairs report in AIDS. Taking at least two medications in addition to triple ART was associated with a 50% ... full story

Tue, 15 May 2018

Living with HIV more than doubles the risk of erectile dysfunction in middle-aged MSM

Living with HIV is an independent risk factor for erectile problems among middle-aged men who have sex with men (MSM), Dutch investigators report in the online edition of AIDS. After taking into account all other risk factors, HIV infection was associated with a more than doubling in the risk of ... full story

Mon, 14 May 2018

HIV may increase the risk of skin cancer

People living with HIV may have an increased risk of some types of skin cancer, Danish researchers report in the online edition of the Journal of the American Academy of Dermatology. The investigators compared the risk of basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and malignant melanoma (MM) between HIV-positive ... full story

Wed, 09 May 2018


You can read older stories on the NAM aidsmap news page.